| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |